GB951767A - Improvements in or relating to pharmaceutical compositions and the preparation thereof - Google Patents

Improvements in or relating to pharmaceutical compositions and the preparation thereof

Info

Publication number
GB951767A
GB951767A GB9499/60A GB949960A GB951767A GB 951767 A GB951767 A GB 951767A GB 9499/60 A GB9499/60 A GB 9499/60A GB 949960 A GB949960 A GB 949960A GB 951767 A GB951767 A GB 951767A
Authority
GB
United Kingdom
Prior art keywords
specified
dehydro
phenylephrine
suspensions
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB9499/60A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB951767A publication Critical patent/GB951767A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • C07D457/08Lysergic acid amides in which the amide nitrogen is a member of a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical compositions comprise 1-dehydro-6-alpha-methylhydrocortisone, a 21-acylate thereof wherein the acyl group is that of an organic carboxylic acid containing from 1 to 12 carbon atoms inclusive, or a water-soluble salt of said acylates formed by polybasic carboxylic acids of 1 to 12 carbon atoms in which one carboxyl group is used in acylating the hydroxy group at the 21-position of the 1-dehydro-6-alpha-methyl analogue of hydrocortisone, a decongestant, and a pharmaceutically acceptable carrier. Specified decongestants are phenylephrine and its hydrochloride, theophylline or beta-(ortho-methoxy phenyl)-isopropyl methylamine hydrochloride. Specified water-soluble salts are the sodium, potassium, phenylephrine and N-methyl glucamine salts of the polybasic acid mono-esters. Specified pharmaceutical forms for enteral, parenteral and topical application are capsules, lozenges, pills, pilules, tablets, elixirs, solutions, syrups, sterile solutions and suspensions, dry sterile carriers, bougies, ointments, pastes, suppositories, inhalations, lotions, sprays and suspensions. Liquid topical forms may be pressurized. The compositions may contain disintegrators, lubricants, binders, flavours, sweetening agents, surfactants or preservatives, e.g. myristyl gamma-picolurium chloride. The composition may contain neomycin. Specification 853,981 is referred to.
GB9499/60A 1959-03-25 1960-03-17 Improvements in or relating to pharmaceutical compositions and the preparation thereof Expired GB951767A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80169259A 1959-03-25 1959-03-25

Publications (1)

Publication Number Publication Date
GB951767A true GB951767A (en) 1964-03-11

Family

ID=25181809

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9499/60A Expired GB951767A (en) 1959-03-25 1960-03-17 Improvements in or relating to pharmaceutical compositions and the preparation thereof

Country Status (3)

Country Link
BE (1) BE588797A (en)
FR (1) FR282M (en)
GB (1) GB951767A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180364A1 (en) * 2000-08-15 2002-02-20 Octagene GmbH Steroid hormones as transfer agents

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180364A1 (en) * 2000-08-15 2002-02-20 Octagene GmbH Steroid hormones as transfer agents
WO2002013791A2 (en) * 2000-08-15 2002-02-21 Octagene Gmbh Steroid hormones as transfer agents
WO2002013791A3 (en) * 2000-08-15 2003-02-13 Octagene Gmbh Steroid hormones as transfer agents

Also Published As

Publication number Publication date
FR282M (en) 1961-03-13
BE588797A (en) 1960-09-19

Similar Documents

Publication Publication Date Title
Du Vigneaud The structure of biotin
ATE1374T1 (en) DEVICE FOR TRANSFERRING SIGNS TO OBJECTS.
GB951767A (en) Improvements in or relating to pharmaceutical compositions and the preparation thereof
GB8620917D0 (en) Platinum derivatives & cancer treatments
DE3563971D1 (en) 1-alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them
ES2065343T3 (en) NEW PHARMACEUTICAL PREPARATIONS AS WELL AS NEW LACTOSIL COMPOUNDS AND THEIR PREPARATION.
AU566233B2 (en) Flowable oxytetracycline hydrochloride
EP0301474A3 (en) New cysteine derivatives having expectorant activity
GB971243A (en) Substituted 4-phenylaminoquinolines
Ishihara et al. Studies on actinoleukin, relation to echinomycin and levomycin
GB972672A (en) Pharmaceutical preparations containing compounds of the androstane series
JPS5434773A (en) Vacuum tweezers
FR2305976B1 (en)
JPS5247283A (en) Apparatus for detaching hook of a hanger for supporting shaft-like art icles
GB794483A (en) Steroid compounds and process
TH2666A (en) Modification of Cefarosporin Derivatives or Related Substances
JPS55157595A (en) Weak basic nitrogen-containing compound amylostatin y
KR840005730A (en) Method for preparing a compound having analgesic and anti-inflammatory action
TH2666EX (en) Modification of cefarosporin derivatives or related substances
FR1271406A (en) Process for preparing a cuprous phthalocyanine pigment mainly in alpha form and stable to recrystallization
GB917575A (en) Pharmaceutical anti-inflammatory compositions containing glycyrrhetinic acid isomers
GB912594A (en) Apparatus for forming tabs for marking articles
JPS5237375A (en) Device for aranging moving intervals of articles to be carried
AU160675B2 (en) Improvements in or relating to a process for the production of hexamethylene - 1:6 - bis-trimethylammonium bitartrate and pharmaceutical preparations containing same
GB908634A (en) Pharmaceutical compositions containing pararosaniline or derivatives thereof